Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19197 | 517 | 27.8 | 44% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
475 | 3 | RABIES//MEASLES//RABIES VIRUS | 23887 |
1190 | 2 | MEASLES//RUBELLA//IMMUNIZATION | 9278 |
19197 | 1 | NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUP NITAG//NEW VACCINES//ADVISORY COMMITTEE | 517 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUP NITAG | authKW | 295307 | 1% | 100% | 5 |
2 | NEW VACCINES | authKW | 264670 | 2% | 41% | 11 |
3 | ADVISORY COMMITTEE | authKW | 238201 | 2% | 37% | 11 |
4 | PROVAC INITIAT | address | 236246 | 1% | 100% | 4 |
5 | GAVI ALLIANCE | authKW | 236242 | 1% | 67% | 6 |
6 | IMMUNIZAT VACCINES BIOL | address | 222688 | 6% | 13% | 29 |
7 | IMMUNIZATION FINANCING | authKW | 210931 | 1% | 71% | 5 |
8 | ADVISORY GROUP | authKW | 188995 | 1% | 80% | 4 |
9 | NITAG | authKW | 188995 | 1% | 80% | 4 |
10 | VIAL SIZE | authKW | 177184 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Medicine, Research & Experimental | 5368 | 38% | 0% | 197 |
2 | Immunology | 4559 | 45% | 0% | 233 |
3 | Health Policy & Services | 3214 | 13% | 0% | 68 |
4 | Health Care Sciences & Services | 1691 | 13% | 0% | 65 |
5 | Public, Environmental & Occupational Health | 988 | 19% | 0% | 97 |
6 | Social Sciences, Biomedical | 191 | 3% | 0% | 14 |
7 | Tropical Medicine | 123 | 3% | 0% | 13 |
8 | Infectious Diseases | 117 | 5% | 0% | 27 |
9 | Biotechnology & Applied Microbiology | 81 | 7% | 0% | 35 |
10 | Medical Ethics | 41 | 1% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROVAC INITIAT | 236246 | 1% | 100% | 4 |
2 | IMMUNIZAT VACCINES BIOL | 222688 | 6% | 13% | 29 |
3 | CHILDRENS VACCINE PROGRAM | 157495 | 1% | 67% | 4 |
4 | COMPREHENS FAMILY IMMUNIZAT PROJECT | 120574 | 1% | 29% | 7 |
5 | PUBL HLTH COMPUTAT OPERAT PHICOR GRP | 75933 | 1% | 43% | 3 |
6 | PUBL HLTH COMPUTAT OPERAT PHICOR | 64300 | 1% | 16% | 7 |
7 | ATRAS ESCUELA CIEGOS PILAR SALINAS | 59061 | 0% | 100% | 1 |
8 | AUSTRALIAN TECH ADVISORY GRP IMMUNISAT | 59061 | 0% | 100% | 1 |
9 | BIOMED ENTERPRISE PROGRAM | 59061 | 0% | 100% | 1 |
10 | COMMUNICABLE DIS COMMISS HAUT CONSEIL SANTE PUBL | 59061 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VACCINE | 116247 | 36% | 1% | 188 |
2 | HEALTH POLICY AND PLANNING | 11924 | 3% | 1% | 18 |
3 | HUMAN VACCINES | 11188 | 2% | 2% | 10 |
4 | HEALTH AFFAIRS | 9099 | 5% | 1% | 27 |
5 | BULLETIN OF THE WORLD HEALTH ORGANIZATION | 6913 | 4% | 1% | 20 |
6 | EXPERT REVIEW OF VACCINES | 6818 | 2% | 1% | 12 |
7 | BIOLOGICALS | 2116 | 1% | 1% | 7 |
8 | HUMAN VACCINES & IMMUNOTHERAPEUTICS | 1250 | 1% | 0% | 6 |
9 | JOURNAL OF HEALTH POPULATION AND NUTRITION | 1037 | 1% | 0% | 4 |
10 | JOURNAL OF PUBLIC HEALTH POLICY | 969 | 1% | 1% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUP NITAG | 295307 | 1% | 100% | 5 | Search NATIONAL+IMMUNIZATION+TECHNICAL+ADVISORY+GROUP+NITAG | Search NATIONAL+IMMUNIZATION+TECHNICAL+ADVISORY+GROUP+NITAG |
2 | NEW VACCINES | 264670 | 2% | 41% | 11 | Search NEW+VACCINES | Search NEW+VACCINES |
3 | ADVISORY COMMITTEE | 238201 | 2% | 37% | 11 | Search ADVISORY+COMMITTEE | Search ADVISORY+COMMITTEE |
4 | GAVI ALLIANCE | 236242 | 1% | 67% | 6 | Search GAVI+ALLIANCE | Search GAVI+ALLIANCE |
5 | IMMUNIZATION FINANCING | 210931 | 1% | 71% | 5 | Search IMMUNIZATION+FINANCING | Search IMMUNIZATION+FINANCING |
6 | ADVISORY GROUP | 188995 | 1% | 80% | 4 | Search ADVISORY+GROUP | Search ADVISORY+GROUP |
7 | NITAG | 188995 | 1% | 80% | 4 | Search NITAG | Search NITAG |
8 | VIAL SIZE | 177184 | 1% | 100% | 3 | Search VIAL+SIZE | Search VIAL+SIZE |
9 | VACCINE POLICY | 164335 | 2% | 35% | 8 | Search VACCINE+POLICY | Search VACCINE+POLICY |
10 | IMMUNIZATION POLICY | 159453 | 2% | 30% | 9 | Search IMMUNIZATION+POLICY | Search IMMUNIZATION+POLICY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | OZAWA, S , GREWAL, S , PORTNOY, A , SINHA, A , ARILOTTA, R , STACK, ML , BRENZEL, L , (2016) FUNDING GAP FOR IMMUNIZATION ACROSS 94 LOW- AND MIDDLE-INCOME COUNTRIES.VACCINE. VOL. 34. ISSUE 50. P. 6408 -6416 | 17 | 94% | 0 |
2 | NORMAN, BA , RAJGOPAL, J , LIM, J , GORHAM, K , HAIDARI, L , BROWN, ST , LEE, BY , (2015) MODULAR VACCINE PACKAGING INCREASES PACKING EFFICIENCY.VACCINE. VOL. 33. ISSUE 27. P. 3135 -3141 | 16 | 94% | 0 |
3 | BROWN, ST , SCHREIBER, B , CAKOUROS, BE , WATESKA, AR , DICKO, HM , CONNOR, DL , JAILLARD, P , MVUNDURA, M , NORMAN, BA , LEVIN, C , ET AL (2014) THE BENEFITS OF REDESIGNING BENIN'S VACCINE SUPPLY CHAIN.VACCINE. VOL. 32. ISSUE 32. P. 4097 -4103 | 12 | 100% | 4 |
4 | TOZAN, Y , (2016) CURRENT ISSUES IN THE ECONOMICS OF VACCINATION AGAINST DENGUE.EXPERT REVIEW OF VACCINES. VOL. 15. ISSUE 4. P. 519 -528 | 25 | 32% | 3 |
5 | VAN DER PUTTEN, IM , EVERS, SMAA , DEOGAONKAR, R , JIT, M , HUTUBESSY, RCW , (2015) STAKEHOLDERS' PERCEPTION ON INCLUDING BROADER ECONOMIC IMPACT OF VACCINES IN ECONOMIC EVALUATIONS IN LOW AND MIDDLE INCOME COUNTRIES: A MIXED METHODS STUDY.BMC PUBLIC HEALTH. VOL. 15. ISSUE . P. - | 14 | 67% | 1 |
6 | BRENZEL, L , YOUNG, D , WALKER, DG , (2015) COSTS AND FINANCING OF ROUTINE IMMUNIZATION: APPROACH AND SELECTED FINDINGS OF A MULTI-COUNTRY STUDY (EPIC).VACCINE. VOL. 33. ISSUE . P. A13 -A20 | 11 | 73% | 8 |
7 | BLAU, J , SADR-AZODI, N , CLEMENTZ, M , ABEYSINGHE, N , CAKMAK, N , DUCLOS, P , JANUSZ, C , JAUREGUI, B , MIHIGO, R , MOSINA, L , ET AL (2013) INDICATORS TO ASSESS NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUPS (NITAGS).VACCINE. VOL. 31. ISSUE 23. P. 2653-2657 | 11 | 85% | 2 |
8 | JANUSZ, CB , CASTANEDA-ORJUELA, C , AGUILERA, IBM , GARCIA, AGF , MENDOZA, L , DIAZ, IY , RESCH, SC , (2015) EXAMINING THE COST OF DELIVERING ROUTINE IMMUNIZATION IN HONDURAS.VACCINE. VOL. 33. ISSUE . P. A53 -A59 | 9 | 90% | 6 |
9 | LEE, BY , CONNOR, DL , WATESKA, AR , NORMAN, BA , RAJGOPAL, J , CAKOUROS, BE , CHEN, SI , CLAYPOOL, EG , HAIDARI, LA , KARIR, V , ET AL (2015) LANDSCAPING THE STRUCTURES OF GAVI COUNTRY VACCINE SUPPLY CHAINS AND TESTING THE EFFECTS OF RADICAL REDESIGN.VACCINE. VOL. 33. ISSUE 36. P. 4451 -4458 | 10 | 83% | 1 |
10 | BURCHETT, HED , MOUNIER-JACK, S , GRIFFITHS, UK , BIELLIK, R , ONGOLO-ZOGO, P , CHAVEZ, E , SARMA, H , UDDIN, J , KONATE, M , KITAW, Y , ET AL (2012) NEW VACCINE ADOPTION: QUALITATIVE STUDY OF NATIONAL DECISION-MAKING PROCESSES IN SEVEN LOW- AND MIDDLE-INCOME COUNTRIES.HEALTH POLICY AND PLANNING. VOL. 27. ISSUE . P. II5 -II16 | 15 | 58% | 7 |
Classes with closest relation at Level 1 |